New hires and promotions in the biopharma industry, including: Akoya, Ankyra, Apie, Beam, Cytovation, Decibel, Gamida Cell, Nextpoint, Sonata, Wugen.

The top 10 med-tech stock gainers and losers for the week.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Affamed, Asensus Surgical, Cue Health, Lunit, Surgvision.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Brain Scientific, Detection Technology, Genetworx, Imac Holdings, Oxford Nanopore, Northern Light, Quest Diagnostics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Castle Biosciences, Dermasensor.

New hires and promotions in the med-tech industry, including: Boston Imaging, Inspiremd.

The top 10 biopharma stock gainers and losers for the week.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ipsen, Kuria, Likang, Novartis, Pfizer, Sarepta.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acer, Bristol Myers Squibb, Canbridge, Hanmi, Janssen, Jounce, Leo, Matrivax, Merck, Pfizer.

Biopharmas raising money in public or private financings, including: Appili.